Prestige Consumer Healthcare Inc. (PBH) Earnings Call Analysis

NYSE · Healthcare · Drug Manufacturers - Specialty & Generic

21/25

Growth 5 Margin 4 Expansion 5 Platform 2 Financial 5

latest quarter score

Earnings Reports

21
Prestige Consumer Healthcare (PBH) Q1 2027: Acquisitions Add 20% to Revenue Base, Portfolio Diversifies Further
August 07, 2026
19
Prestige Consumer Healthcare (PBH) Q3 2026: $150M Buyback Accelerates as Channel Shifts and Eye Care Recovery Shape Outlook
June 15, 2026
18
Prestige Consumer Healthcare (PBH) Q4 2026: Eye Care Supply Disruption Drives 5% Revenue Decline, Sets Up FY27 Recovery
May 14, 2026
18
Prestige Consumer Healthcare (PBH) Q2 2026: $134M Free Cash Flow Fuels Buybacks Amid Eye Care Recovery
November 06, 2025
14
Prestige Consumer Healthcare (PBH) Q1 2026: Clear Eyes Supply Disruption Drives 8% North America Drop, Pillar 5 Acquisition Targets Recovery
August 07, 2025
21
Prestige Consumer Healthcare (PBH) Q4 2025: E-Commerce Climbs to High-Teens Share, Accelerating Channel Shift
July 07, 2025

Browse all companies